TAKHZYRO was also studied in children

In the 52-week study, there were:

• No serious side effects reported
• No discontinuations due to side effects
• No allergic reactions related to TAKHZYRO

Most common related TEAEs in children taking TAKHZYRO 150 mg every 2 or 4 weeks (21 children, aged 2 to <12 years)

• Injection site pain: 29%
• Injection site redness: 14%
• Injection site swelling: 5%
• Administration site pain: 5%
• Injection site reaction: 5%

TEAE=treatment-emergent adverse event.

Before you use TAKHZYRO, tell your healthcare provider about all of your child’s medical conditions.

Tell your healthcare provider about all the medicines you or your child take, including prescription medicines, over-the-counter medicines, vitamins, or herbal supplements.